KINKINEPOLIS GROUP


$ 9.25 $ 0.01 (0.11 %)    

Friday, 27-Aug-2021 15:50:01 EDT
QQQ $ 468.86 $ 0.00 (0 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 9.25
-- x --
-- x --
-- - --
$ 3.46 - $ 9.28
178,496
na
nm
$ 1.35
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 3-stocks-insiders-are-buying
3 Stocks Insiders Are Buying
08/31/2021 12:14:10

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a ba...

 4-stocks-insiders-are-selling
4 Stocks Insiders Are Selling
08/05/2021 14:08:16

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overprice...

 looking-into-kindred-biosciencess-return-on-capital-employed

Kindred Biosciences (NASDAQ:KIN) reported Q1 sales of $2.40 million. Earnings fell to a loss of $9.17 million, resulting in a 1...

 the-daily-biotech-pulse-orphazyme-falters-at-fda-athiras-ceo-placed-on-temporary-leave-5-ipos

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 lake-street-downgrades-kindred-biosciences-to-hold-lowers-price-target-to-925

Lake Street analyst Brooks O'Neil downgrades Kindred Biosciences (NASDAQ: KIN) from Buy to Hold and lowers the price tar...

Core News & Articles

  This morning 94 companies set new 52-week highs.

 hc-wainwright--co-downgrades-kindred-biosciences-to-neutral-raises-price-target-to-925

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Kindred Biosciences (NASDAQ: KIN) from Buy to Neutral and ...

 the-daily-biotech-pulse-biogen-faces-another-clinical-setback-curevacs-covid-19-vaccine-study-fails-moment-of-reckoning-for-orphazyme

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 48-biggest-movers-from-yesterday
48 Biggest Movers From Yesterday
06/17/2021 09:07:26

Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) shares jumped 95.1% to close at $7.98 on Wednesday. Gaucho Group highligh...

Core News & Articles

Toward the end of trading Wednesday, the Dow traded down 0.92% to 33,983.29 while the NASDAQ fell 0.68% to 13,977.59. The S&...

Core News & Articles

Kindred Biosciences, Inc. (NASDAQ: KIN), Aprea Therapeutics, Inc. (NASDAQ: APRE), Catabasis Pharmaceuticals, Inc.

Core News & Articles

Midway through trading Wednesday, the Dow traded down 0.12% to 34,259.48 while the NASDAQ rose 0.20% to 14,100.31. The S&P ...

Core News & Articles

Gainers Opthea Limited (NASDAQ: OPT) shares surged 50.7% to $13.28. The company recently appointed Mrs. Karen Adams as Vice ...

Core News & Articles

Following the market opening Wednesday, the Dow traded down 0.15% to 34,247.35 while the NASDAQ rose 0.36% to 14,123.49. The S&...

Core News & Articles

    Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs.

 aegis-capital-downgrades-kindred-biosciences-to-hold-lowers-price-target-to-925

Aegis Capital analyst Nathan Weinstein downgrades Kindred Biosciences (NASDAQ:KIN) from Buy to Hold and lowers the price tar...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION